Health Care & Life Sciences » Biotechnology | Grifols

Grifols

Grifols S.A. ADR
Stock Exchange Other OTC
EPS
 $0.48
Market Cap
 $13.31 B
Shares Outstanding
 852.26 M
Public Float
 -
Grifols S.A.
Stock Exchange Frankfurt Stock Exchange
EPS
 -
Market Cap
 -
Shares Outstanding
 -
Public Float
 -
Grifols S.A. ADR
Stock Exchange NASDAQ Stock Market
EPS
 $0.96
Market Cap
 $5.58 B
Shares Outstanding
 261.43 M
Public Float
 -

Profile

Address
Avinguda de la Generalitat, 152-158
Barcelona Catalonia 08174
Spain
Employees -
Website http://www.grifols.com
Updated 07/08/2019
Grifols SA is a vertically integrated global producer of plasma derivatives. Its activities include sourcing raw material, manufacturing various plasma derivative products and selling and distributing final products to healthcare providers. The company operates through the following segments: Bioscience, Hospital, Diagnostic and Raw Materials.

Financials

View All
Created with Highcharts 5.0.14Grifols S.A.Net Income. Fiscal year is January-December. All values EUR Millions.3463464704705325325455456636635975972013201420152016201720180200400600800
Created with Highcharts 5.0.14Grifols S.A.Sales/Revenue. Fiscal year is January-December. All values EUR Millions.2 7422 7423 3553 3553 9353 9354 0504 0504 3184 3184 4874 48720132014201520162017201801k2k3k4k5k

Víctor Grifols Roura
Non-Executive Chairman
Victor Grifols Deu
Joint Chief Executive Officer & Executive Director
View All

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.